Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Director Arthur F. Ryan Sells 100 Shares

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) Director Arthur F. Ryan sold 100 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $716.88, for a total transaction of $71,688.00. Following the completion of the sale, the director now owns 18,747 shares […]

Related Keywords

Arthurf Ryan ,Raymond James ,Quent Capital ,News Ratings For Regeneron Pharmaceuticals Daily ,Joel Isaacson Co ,Canaccord Genuity Group ,Nasdaq ,Regeneron Pharmaceuticals ,Securities Exchange Commission ,Regeneron Pharmaceuticals Inc ,Quarter For Regeneron Pharmaceuticals ,Institutional Trading Of Regeneron Pharmaceuticals ,Morgan Stanley ,Regeneron Pharmaceuticals Company Profile ,Colonial River Wealth Management ,Equitable Holdings Inc ,Erste Group Bank ,Regeneron Pharmaceuticals Stock Down ,Free Report ,Director Arthur ,Exchange Commission ,Pharmaceuticals Stock Down ,Group Bank ,Street Advisors ,River Wealth Management ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Insider Trading ,Nsider Trades ,Stocks ,